home Lung Cancer Merck drug results suggest it will extend its lead in lung cancer; Bristol–Myers shares drop Merck drug results suggest it will extend its lead in lung cancer; Bristol–Myers shares drop By Posted in Lung Cancer Posted on June 21, 2018
